Simudyne
PrivateLast Round
Series A
Apr 8, 2019
Est. Valuation
$16.1M
Total Funding Raised
$12.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Simudyne is a software company that provides an enterprise simulation platform using agent-based modeling and AI for financial institutions to test decisions and manage risk.
Sector
Enterprise Software
Verticals
Compliance & Risk, Business Intelligence, RegTech
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Usage-Based SaaS
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Simudyne Comparables
Compare Simudyne with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Quantum Technology Solutions Limited | 77% | |
| Cosmo Tech | 74% | |
| Epistemix | 70% | |
Simudyne Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 8, 2019 | ||||
| Accelerator | Oct 2, 2018 | ||||
| Seed | Feb 16, 2018 | ||||
| Accelerator | May 3, 2017 | ||||
| Accelerator | Dec 11, 2015 |
Key People
Founding team and executive leadership
Simudyne Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Barclays PLC | Series A |
| CyLon | Accelerator |
| Techstars | Accelerator, Seed |
| Calibrate Ventures | Seed |
| Barclays Accelerator | Accelerator |
| Sway Ventures | Seed |
| Graphene Ventures | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 23, 2026
Grew 24% QoQ, from 17 to 21 employees.
- May 17, 2026
Monthly visitors increased 47% MoM.
Simudyne Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Simudyne's valuation, stock price, and market status.